ADAKVEO (crizanlizumab-tmca) injection for intravenous use
Product Brand Name: ADAKVEO. API Name: crizanlizumab-tmca. ADAKVEO (crizanlizumab-tmca) injection is indicated For to reduce the frequency of vaso-occlusive crises (VOCs) in adults and pediatric patients aged 16 years and older with sickle cell disease.
- Active ingredient: crizanlizumab-tmca. Inactive ingredients: acetate, polysorbate 20, sodium, and sorbitol in water for injection.
- API – crizanlizumab-tmca
- Brand name – ADAKVEO (crizanlizumab-tmca) injection, for intravenous use Initial U.S. Approval: 2019
- Strength – Injection: 100 mg/10 mL (10 mg/mL) solution in a single-dose vial.
For Best Price: To know the best price of the product available with Lucknow Speciality Pharma call at Contact No. 9760014849, 9555306364, 9794360370, 9140551027 or email us at info@lucknowpharma.com
Disclaimer: All Trademarks and Brands that appear on the website belong to their respective owners and Lucknow Speciality Pharma (www.lucknowpharma.com) does not lay any claim on them we only provide Information.
Enter Buying Requirements Details
For precise quotations, kindly ensure your requirements include the product name, order quantity, intended usage, and any special requests you may have.
About Us
Lucknow Speciality Pharma is a registered Pharmaceutica Firm in Lucknow, India. Registered under GST Act. Registration Number : 09AAOPG3102HIZY. It provide assistance and connectivity with drug pharmacies or distributors for access to genuine medicines at competitive prices.
Get Access To ADAKVEO (crizanlizumab-tmca) injection for intravenous use
Branch Offices in India : Lucknow | Agra | Varanasi | Gorakhpur | Kanpur | Nepal
Crizanlizumab, is a monoclonal antibody medication that binds to P-selectin. It is a medication used to reduce the frequency of vaso-occlusive crisis in people aged 16 years and older who have sickle cell anaemia. It is given by injection into a vein.
Crizanlizumab was approved for medical use in the United States in November 2019. The EU's EMA withdrew authorization in May 2023 based on no significant effects from a phase 3 trial. The U.S. Food and Drug Administration (FDA) considers it to be a first-in-class medication.
crizanlizumab-tmca is available in India on request-
Lucknow Speciality Pharma is the leading Pharma brand and one of the most leading Pharma Wholesalers in Lucknow. We are expanding our reach across India. To get “ADAKVEO (crizanlizumab-tmca) injection“, patients can simply fill the order form or can send mail at info@lucknowpharma.com. Patients can also send WhatsApp messages to +91-9555306364, The order will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.
Medicines Delivered
We have supplied to following cities in India-
Lucknow Speciality Pharma has delivered “ADAKVEO (crizanlizumab-tmca) injection“ in Kanpur, Lucknow, Ghaziabad, Agra, Meerut, Varanasi, Prayagraj, Bareilly, Aligarh, Moradabad, Saharanpur, Gorakhpur, Noida, Firozabad, Jhansi, Muzaffarnagar, Mathura-Vrindavan, Ayodhya, Rampur, Shahjahanpur, Farrukhabad-Fatehgarh, Budaun, Maunath, Hapur, Etawah, Mirzapur-Vindhyachal, Bulandshahr, Sambhal, Amroha, Hardoi, Fatehpur, Raebareli, Orai, Sitapur, Bahraich, Modinagar, Unnao, Jaunpur, Lakhimpur, Hathras, Banda, Pilibhit, Barabanki, Khurja, Gonda, Mainpuri, Lalitpur, Etah, Deoria, Badaun, Ghazipur, Sultanpur, Azamgarh, Bijnor, Sahaswan, Basti, Chandausi, Akbarpur, Ballia, Ambedkar Nagar, Greater Noida, Shikohabad, Patna, Gaya, Bhagalpur, Muzaffarpur, Darbhanga, Siwan, Sasaram, Hajipur, Burdwan, Kolkata, Kharagpur, Asansol, Haldia, Siliguri, Howrah, Imphal, Guwahati and Agartala and Nepal.
Contact Patient Support
If you have any questions or need any help, contact our Patient Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 AM and 7:00 PM IST.
Landline :
05226180025
Mobile :
9555306364, 9794360370, 9140551027
WhatsApp:
+91-9760014849
Email:
info@lucknowpharma.com
